“Value assessment has the potential to positively impact so many sectors of the healthcare ecosystem,” said Jennifer Bright, IVI executive director. “Our new directors come from different corners of healthcare and research and will bring important perspectives to the table. I look forward to their contributions moving forward.” The newly elected board members, whose terms began January 1, include:
· John Banta, MBA, President, Managing Director, BlueCross BlueShield Venture Partners
· Kirsten Beronio, JD, Director of Policy and Regulatory Affairs, National Association of Behavioral Healthcare
· Harold Carter, PharmD, Vice President,…